Capstone Asset Management’s Avanos Medical AVNS Stock Holding History

Capstone Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$222K	Buy	5,663 +330	+6%	+$12.5K	0.01%	1459
2017 Q1	$203K	Buy	+5,333	New	+$208K	0.01%	1528
2015 Q4	–	Sell	-7,454	Closed	-$212K	–	1600
2015 Q3	$212K	Buy	7,454 +539	+8%	+$18.8K	0.01%	1456
2015 Q2	$280K	Sell	6,915 -359	-5%	-$16.1K	0.01%	1346
2015 Q1	$358K	Buy	7,274 +490	+7%	+$22.7K	0.01%	1290
2014 Q4	$308K	Buy	+6,784	New	+$267K	0.01%	1354

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Capstone Asset Management's AVNS Position: Q2 2017 in Review

Capstone Asset Management increased its Avanos Medical (AVNS) stake by 6.2% in Q2 2017, buying an estimated $12.5K and bringing the position to 5,663 shares worth $222K. The position accounts for 0.01% of the portfolio, ranked #1459.

Capstone Asset Management first reported a position in AVNS in Q4 2014 and has held it in 6 quarters since. The position peaked at $358K in Q1 2015. 328 funds tracked by Wall St. Rank hold AVNS as of Q2 2017.

Capstone Asset Management held 5,663 shares of Avanos Medical worth $222K as of Q2 2017.
Capstone Asset Management bought 330 Avanos Medical shares in Q2 2017, an estimated $12.5K.
Avanos Medical made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1459 holding.
Capstone Asset Management first reported a position in Avanos Medical in Q4 2014 and has held it in 6 quarters since.
Capstone Asset Management's Avanos Medical position peaked at $358K in Q1 2015.
328 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.